Dr. Alan Koletsky, MD

NPI: 1952359234
Total Payments
$77,682
2023 Payments
$884.35
Companies
55
Transactions
538
Medicare Patients
2,513
Medicare Billing
$312,033

Payment Breakdown by Category

Other$34,120 (43.9%)
Consulting$18,980 (24.4%)
Travel$12,356 (15.9%)
Food & Beverage$11,460 (14.8%)
Education$766.42 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,230 9 38.9%
Consulting Fee $18,980 10 24.4%
Travel and Lodging $12,356 33 15.9%
Food and Beverage $11,460 468 14.8%
Honoraria $3,890 4 5.0%
Education $766.42 14 1.0%

Top Paying Companies

Company Total Records Latest Year
Exelixis Inc. $29,527 48 $0 (2023)
E.R. Squibb & Sons, L.L.C. $12,876 39 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $8,641 13 $0 (2022)
GENZYME CORPORATION $6,425 17 $0 (2023)
PFIZER INC. $3,918 102 $0 (2023)
Hoffmann-La Roche Limited $2,867 7 $0 (2018)
Astellas Pharma Global Development $2,241 1 $0 (2021)
Merck Sharp & Dohme LLC $1,860 43 $0 (2023)
Seagen Inc. $1,731 5 $0 (2023)
AVEO Pharmaceuticals, Inc. $1,137 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $884.35 33 Sirtex Medical Inc ($274.82)
2022 $3,571 64 Seagen Inc. ($1,696)
2021 $6,715 39 Astellas Pharma Global Development ($2,241)
2020 $3,808 19 Bayer HealthCare Pharmaceuticals Inc. ($1,844)
2019 $3,950 110 Exelixis Inc. ($2,033)
2018 $24,281 116 Exelixis Inc. ($11,251)
2017 $34,473 157 Exelixis Inc. ($16,192)

All Payment Transactions

538 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
09/27/2023 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $19.24 General
Category: Oncology
06/21/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $20.01 General
Category: Oncology
06/20/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $33.28 General
Category: Oncology
06/14/2023 PFIZER INC. XTANDI (Drug) Food and Beverage In-kind items and services $17.25 General
Category: ONCOLOGY
06/07/2023 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $23.34 General
Category: Oncology
06/06/2023 ARRAY BIOPHARMA INC LORBRENA (Drug), BRAFTOVI, MEKTOVI Food and Beverage In-kind items and services $20.23 General
Category: ONCOLOGY
05/31/2023 Amgen Inc. Kyprolis (Drug) Food and Beverage In-kind items and services $14.78 General
Category: Oncology
05/30/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $14.93 General
Category: Oncology
05/24/2023 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $24.02 General
Category: Oncology
05/17/2023 SOBI, INC Doptelet (Drug) Food and Beverage In-kind items and services $21.43 General
Category: HEMATOLOGY/ONCOLOGY
05/17/2023 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $17.67 General
Category: ONCOLOGY
05/17/2023 Seagen Inc. ADCETRIS (Biological) Food and Beverage In-kind items and services $12.99 General
Category: Oncology
05/16/2023 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $125.70 General
Category: Interventional Oncology
05/09/2023 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $149.12 General
Category: Interventional Oncology
04/19/2023 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $19.38 General
Category: Hematology/Oncology
04/11/2023 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $21.53 General
04/06/2023 Exelixis Inc. CABOMETYX (Drug) Food and Beverage Cash or cash equivalent $12.79 General
Category: Oncology
03/28/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $25.59 General
Category: ONCOLOGY
03/21/2023 Deciphera Pharmaceuticals Inc. QINLOCK (Drug) Food and Beverage In-kind items and services $20.33 General
Category: ONCOLOGY
03/14/2023 Eisai Inc. Lenvima (Drug) Food and Beverage Cash or cash equivalent $23.33 General
Category: Oncology
03/10/2023 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $13.64 General
Category: Oncology
03/07/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $14.79 General
Category: Oncology
03/02/2023 Mirati Therapeutics, Inc. KRAZATI (Drug) Food and Beverage In-kind items and services $24.71 General
Category: ONCOLOGY
03/01/2023 Mirati Therapeutics, Inc. KRAZATI (Drug) Education In-kind items and services $21.00 General
Category: ONCOLOGY
02/23/2023 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $16.33 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 283 476 $108,159 $29,567
2022 4 718 1,412 $351,822 $102,531
2021 6 687 1,395 $315,246 $93,369
2020 8 825 1,772 $308,727 $86,567
Total Patients
2,513
Total Services
5,055
Medicare Billing
$312,033
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 96 144 $37,460 $10,161 27.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 71 120 $31,345 $8,850 28.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 56 113 $20,971 $5,505 26.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 60 99 $18,384 $5,051 27.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 189 377 $100,544 $29,801 29.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 188 370 $98,710 $29,045 29.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 111 254 $48,518 $13,128 27.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 88 215 $40,857 $10,981 26.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 72 84 $31,819 $9,400 29.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 56 64 $24,243 $7,296 30.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 48 $7,131 $2,881 40.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 149 283 $76,670 $23,054 30.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 116 258 $69,897 $20,399 29.2%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 144 319 $60,935 $16,524 27.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 138 300 $57,306 $15,607 27.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 63 153 $22,917 $9,057 39.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 39 44 $16,682 $5,385 32.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $5,307 $1,752 33.0%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 12 12 $4,246 $1,285 30.3%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 11 11 $1,285 $305.80 23.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 198 575 $90,559 $23,148 25.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 93 254 $38,795 $15,342 39.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 117 235 $53,672 $14,166 26.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 141 313 $49,287 $13,070 26.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 116 185 $42,143 $11,318 26.9%

About Dr. Alan Koletsky, MD

Dr. Alan Koletsky, MD is a Specialist healthcare provider based in Delray Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952359234.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Koletsky, MD has received a total of $77,682 in payments from pharmaceutical and medical device companies, with $884.35 received in 2023. These payments were reported across 538 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,230).

As a Medicare-enrolled provider, Koletsky has provided services to 2,513 Medicare beneficiaries, totaling 5,055 services with total Medicare billing of $312,033. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Internal Medicine, Medical Oncology
  • Location Delray Beach, FL
  • Active Since 05/05/2006
  • Last Updated 03/15/2022
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1952359234

Products in Payments

  • Cabometyx (Drug) $27,476
  • OPDIVO (Biological) $12,817
  • Xofigo (Drug) $8,577
  • JEVTANA (Drug) $6,263
  • BAVENCIO (Drug) $2,983
  • PADCEV (Drug) $2,284
  • Non-Covered Product (Drug) $1,921
  • KEYTRUDA (Biological) $1,796
  • PADCEV (Biological) $1,672
  • TECENTRIQ (Biological) $1,291
  • FOTIVDA (Drug) $1,137
  • SIR-Spheres Microspheres (Device) $593.23
  • ERLEADA (Drug) $512.08
  • XTANDI (Drug) $427.43
  • GILOTRIF (Drug) $254.20
  • Erleada (Drug) $250.96
  • Lenvima (Drug) $200.77
  • IMFINZI (Drug) $178.33
  • IMBRUVICA (Drug) $170.27
  • ZEPZELCA (Drug) $153.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Delray Beach